{"GHMDC classification":["Treatment"],"GHMDC health topic":["Maternal mortality"],"GHMDC manufacturer coordinates":["6.6985611111111, -1.6233083333333"],"GHMDC manufacturer location":["Kumasi, Ghana"],"GHMDC scope":["Clinical trial"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Hemafuse"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Ruptured ectopic pregnancy is a leading cause of maternal mortality worldwide and women who suffer are often in need of blood transfusions as they lose considerable amounts of blood. Autologous blood transfusion is an important technique used in resource-poor settings where there are often shortages of donated blood. This method essentially involves physically extracting patients’ blood and re-infusing it back into their bodies through a gauze filter. However, this “soup ladle” model is slow, lacks in sterility and filtering efficacy, is labor-intensive, and potentially dangerous for patients, often resulting in complications related to acute anemia."],"Page image":["File:Hemafuse.png"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Hemafuse"],"Page views":[341],"Page year":["Sunday, 01-Jan-12 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:28:02 UTC"]}